Neurology · 2010 · 127 citations · 33 references
MedicineNeurologyRadiologyDementiaDiagnostic ImagingMemoryBrain ImagingCerebral EdemaCognitive ImpairmentMagnetic Resonance ImagingMemory DisordersWhite Matter DisordersCerebral MicrobleedsMicrobleed ImagingStructural Magnetic Resonance Imaging MarkersWhite Matter AbnormalitiesWhite Matter Hyperintensity MarkersWhite Matter IntegrityWhite Matter LesionsWhite Matter Microstructure
BACKGROUND: Cerebral microbleeds (MBs) are commonly observed in memory clinic patients. Little is known about occurrence of and risk factors for developing new MBs in this population. OBJECTIVE: To investigate incidence of lobar and nonlobar MBs in a memory clinic population. Furthermore, to assess risk factors for the development of new MBs and their associations with other MRI changes. METHODS: A total of 254 patients visiting our memory clinic, with repeat gradient-recalled echo T2*-weighted MRI, were included (scan interval 1.9 +/- 0.9 years). Baseline and incident MBs were regionally counted. White matter hyperintensities (WMH) and progression of WMH were assessed using visual rating scales. Baseline brain volume and whole-brain atrophy rate were estimated automatically. In a subset, APOE was determined. RESULTS: Thirty-one (12%) patients developed new MBs (range 1-19). Both multiple strictly lobar and nonlobar MBs at baseline predicted incident MBs (odds ratio [OR] 8.4; 95% confidence interval [CI] 2.2-33.2, and OR 33.8; 95% CI 8.1-140.8). Furthermore, baseline WMH grade (OR 1.2; 1.1-1.3), lacunar infarcts (OR 2.8; 1.3-6.0), and APOE epsilon2 carriership (OR 4.2; 1.4-12.5) predicted MB incidence. Incident MB patients had more progression of WMH (p < 0.01) and incident lacunar infarcts (p < 0.05). These relations were most prominent for incident nonlobar MBs. Incident strictly lobar MBs were associated with smoking. CONCLUSION: In addition to APOE genotype, presence and progression of small-vessel disease and vascular risk factors were predictors of new MBs. The latter are potentially modifiable, suggesting the possibility of preventing incident MBs, hopefully resulting in slower clinical decline.
33
Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 86.9K citations
Clinical diagnosis of Alzheimer's disease
Guy M. McKhann, David A. Drachman, Marshall Folstein et al. · Neurology · 1984 · 28K citations · Full text
Ronald C. Petersen, Glenn E. Smith, Stephen C. Waring et al. · Archives of Neurology · 1999 · 9K citations
Medicine, Neurology, Psychiatry +17
Gustavo C. Román, T. K. Tatemichi, Timo Erkinjuntti et al. · Neurology · 1993 · 4.9K citations
Medicine, Neurology, Neuroscience +17
Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis
Stephen M. Smith, Yongyue Zhang, Mark Jenkinson et al. · NeuroImage · 2002 · 2.1K citations